The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer

OBJECTIVE: To assess the prognostic value of the systemic immune-inflammation index (SII) in patients with vulvar cancer. METHODS: Data of 130 consecutive patients who underwent primary surgical resection for vulvar cancer at the Medical University of Vienna between 1999 and 2018 was retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartl, Thomas, Bekos, Christine, Postl, Magdalena, Alexander, Reinthaller, Polterauer, Stephan, Stefanie, Aust, Richard, Schwameis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767659/
https://www.ncbi.nlm.nih.gov/pubmed/33185042
http://dx.doi.org/10.3802/jgo.2021.32.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767659/
https://www.ncbi.nlm.nih.gov/pubmed/33185042
http://dx.doi.org/10.3802/jgo.2021.32.e1

Ejemplares similares